Elderly women above screening age diagnosed with cervical cancer have a worse prognosis

Anticancer Research

Volumn 34, Issue 9, 2014, Pages 5147-5151

  Darlin, Lotten ^a   Borgfeldt, Christer ^a   Widén, Emelie ^a   Kannisto, Päivi ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cervical cancer; Cervical screening program; HPV test; Overall survival; Swedish population

Indexed keywords

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL AUDIT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; UTERINE CERVIX CANCER; CERVICAL SCREENING PROGRAM; EARLY DIAGNOSIS; HPV TEST; MASS SCREENING; METHODOLOGY; MORTALITY; PROGNOSIS; SWEDEN; SWEDISH POPULATION; UTERINE CERVIX TUMOR; VERY ELDERLY;

CERVICAL CANCER; CERVICAL SCREENING PROGRAM; HPV TEST; OVERALL SURVIVAL; SWEDISH POPULATION;

ADENOCARCINOMA; AGE FACTORS; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; PROGNOSIS; SWEDEN; UTERINE CERVICAL NEOPLASMS;

EID: 84908675933     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cancer Incidence Sweden 2011: http://www.socialstyrelsen.se/publikationer2012/2012-12-19
2. Andrae B, Kemetli L, Sparen P, Silfverdal L, Strander B, Ryd W, Dillner J and Tornberg S: Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 100: 622-629, 2008.
3. de Bie RP, Vergers-Spooren H C, Massuger LF, Siebers AG, Saletvan der Pol MR, Vedder JE, Melchers WJ, Bulten J and Bekkers RL: Patients with cervical cancer: Why did screening not prevent these cases? Am J Obstet Gynecol 205: 64 e1-7 2011.
4. Bos AB, Rebolj M, Habbema JD and van Ballegooijen M: Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 19: 2372-2375, 2006.
5. Gok M, Rozendaal L, Berkhof J, Visser O, Meijer CJ and van Kemenade FJ: Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases. Br J Cancer 104: 685-692, 2011.
6. Arsrapport Cervixcancerscreeing i sodra sjukvardsregionen 2012; Yearly statistics, published in: www.skane.se/sv/Webbplatser/Regionalt-Cancercentrum/Prevention/Rapporter.
7. SCB, Swedish Official Statistics; 2012, www.scb.se http://www.statistikdatabasen.scb.se/pxweb/sv
8. Causes of death 2012, Socialstyrelsen, www.socialstyrelsen.se/register/dodsorsaksregistret
9. Beckman N, Waern M, Gustafson D and Skoog I: Secular trends in self reported sexual activity and satisfaction in Swedish 70 year olds: cross-sectional survey of four populations 1971-2001. BMJ 337: a279, 2008.
10. Lönnberg S, Anttila A, Luostarinen T and Nieminen P: Agespecific effectiveness of the Finnish cervical cancer screening programme. Cancer Epidemiol Biomarkers Prev 21: 1354-1361, 2012.
11. Gustafsson L, Sparen P, Gustafsson M, Pettersson B, Wilander E, Bergstrom R and Adami HO: Low efficiency of cytologic screening for cancer in situ of the cervix in older women. Int J Cancer 63: 804-809, 1995.
12. Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P and Anttila A: Age-specific evaluation of primary human papillomavirus screening vs. conventional cytology in a randomized setting. J Natl Cancer Inst 101: 1612-1623, 2009.
13. Gyllensten U, Gustavsson I, Lindell M and Wilander E: Primary high-risk HPV screening for cervical cancer in post-menopausal women. Gynecol Oncol 125: 343-345, 2012.
14. de Kok IM, van Rosmalen J, Dillner J, Arbyn M, Sasieni P, Iftner T and van Ballegooijen M: Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model. BMJ 344: e670, 2012.
15. Cox JT, Castle PE, Behrens CM, Sharma A, Wright TC Jr., Cuzick J and Athena HPV Study Group: Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study. Am J Obstet Gynecol 208: 184 e1-184 e11, 2013.
16. Kinney W, Fetterman B, Cox JT, Lorey T, Flanagan T and Castle PE: Characteristics of 44 cervical cancers diagnosed following Pap-negative, high-risk HPV-positive screening in routine clinical practice. Gynecol Oncol 121: 309-313, 2011.
17. Gyllensten U, Lindell M, Gustafsson I and Wilander E: HPV test shows low sensitivity of Pap screen in older women. Lancet Oncol 11: 509-510, author reply 510-511, 2010.
18. Pettersson BF, Hellman K, Vaziri R, Andersson S and Hellstrom AC: Cervical cancer in the screening era: Who fell victim in spite of successful screening programs? J Gynecol Oncol 22: 76-82, 2011.
19. Zucchetto A, Franceschi S, Clagnan E, Serraino D, Zanier L and Franzo A: Screening history of women with invasive cervical cancer in north-east Italy. Eur J Obstet Gynecol Reprod Biol 152: 200-204, 2010.
20. Arbyn M, Anttila A, Jordan J, Ronco G, Schenk U, Segnan N, Wiener H, Herbert A and von Karsa L: European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition Summary Document. Ann Oncol 21(3): 448-458, 2010.
21. Dillner J: Nationellt Kvalitetsregister för Cervix cancer prevention, Center för Cervixcancerprevention, Avdelningen för Patologi, Karolinska Universitetslaboratoriet, F56, Huddinge Sjukhus, 14186 Stockholm. National Cervical Cancer Prevention Registry Report 2013
22. Andrae B, Andersson TM, Lambert PC, Kemetli L, Silfverdal L, Strander B, Ryd W, Dillner J, Tornberg S and Sparen P: Screening and cervical cancer cure: population based cohort study. BMJ 344: e900, 2012
23. Darlin L, Borgfeldt C, Forslund O, Henic E, Hortlund M, Dillner J and Kannisto P: Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening. J Clin Virol 58: 155-160, 2013.
24. Virtanen A, Nieminen P, Luostarinen T and Anttila A: Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in finland: a randomized trial. Cancer Epidemiol Biomarkers Prev 20: 1960-1969, 2011.
25. Spayne J, Ackerman I, Milosevic M and Seidenfeld A, Covens A, and Paszat L: Invasive cervical cancer: a failure of screening. Eur J Public Health 18: 162-165, 2008.